Alimera Sciences, Inc. - stock earnings
ALIM Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 AfterMarket | - / -0.0578000000 | - | - / 22.7 million | - |
ALIM Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -3.8 million USD | 26.3 million USD |
| 2023Q3 | -1.4 million USD | 23.4 million USD |
| 2023Q2 | -10.0 million USD | 17.5 million USD |
| 2023Q1 | -8.3 million USD | 13.5 million USD |
| 2022Q4 | -3.8 million USD | 14.0 million USD |
| 2022Q3 | -5.3 million USD | 13.6 million USD |
| 2022Q2 | -3.1 million USD | 14.6 million USD |
| 2022Q1 | -7.8 million USD | 11.9 million USD |
| 2021Q4 | -4.1 million USD | 14.0 million USD |
| 2021Q3 | -4.2 million USD | 12.2 million USD |
| 2021Q2 | 7.6 million USD | 21.7 million USD |
| 2021Q1 | -3.6 million USD | 11.2 million USD |
| 2020Q4 | -977000 USD | 13.8 million USD |
| 2020Q3 | -618000 USD | 12.5 million USD |
| 2020Q2 | -2.5 million USD | 10.0 million USD |
| 2020Q1 | -1.2 million USD | 14.5 million USD |
| 2019Q4 | 498000 USD | 17.3 million USD |
| 2019Q3 | -3.1 million USD | 12.9 million USD |
| 2019Q2 | -5.0 million USD | 10.9 million USD |
| 2019Q1 | -2.8 million USD | 12.9 million USD |
| 2018Q4 | -1.2 million USD | 15.1 million USD |
| 2018Q3 | -3.5 million USD | 11.1 million USD |
| 2018Q2 | -4.0 million USD | 10.9 million USD |
| 2018Q1 | -7.7 million USD | 9.8 million USD |
| 2017Q4 | -7.2 million USD | 9.1 million USD |
| 2017Q3 | -5.3 million USD | 9.8 million USD |
| 2017Q2 | -2.8 million USD | 10.4 million USD |
| 2017Q1 | -6.7 million USD | 6.6 million USD |
| 2016Q4 | -5.9 million USD | 10.7 million USD |
| 2016Q3 | -9.2 million USD | 8.3 million USD |
| 2016Q2 | -6.9 million USD | 9.6 million USD |
| 2016Q1 | -11.1 million USD | 5.8 million USD |
| 2015Q4 | -10.7 million USD | 5.8 million USD |
| 2015Q3 | -1.5 million USD | 6.9 million USD |
| 2015Q2 | -8.6 million USD | 5.8 million USD |
| 2015Q1 | -9.8 million USD | 3.9 million USD |
| 2014Q4 | -9.3 million USD | 1.7 million USD |
| 2014Q3 | -7.0 million USD | 2.4 million USD |
| 2014Q2 | 1.1 million USD | 2.2 million USD |
| 2014Q1 | -20.8 million USD | 2.1 million USD |
| 2013Q4 | -14.8 million USD | 935000 USD |
| 2013Q3 | -1.1 million USD | 758000 USD |
| 2013Q2 | -16.4 million USD | 179000 USD |
| 2013Q1 | -14.0 million USD | ? USD |
| 2012Q4 | -5.3 million USD | 5000 USD |
| 2012Q3 | -5.4 million USD | ? USD |
| 2012Q2 | -4.7 million USD | ? USD |
| 2012Q1 | -4.4 million USD | ? USD |
| 2011Q4 | -6.1 million USD | ? USD |
| 2011Q3 | -6.5 million USD | ? USD |
| 2011Q2 | -5.2 million USD | ? USD |
| 2011Q1 | -4.7 million USD | ? USD |
| 2010Q4 | -6.3 million USD | 73000 USD |
| 2010Q3 | -6.1 million USD | ? USD |
| 2010Q2 | -4.1 million USD | ? USD |
| 2010Q1 | 2.6 million USD | ? USD |
| 2009Q4 | -22.7 million USD | ? USD |
| 2009Q3 | -5.1 million USD | ? USD |
| 2009Q2 | -6.3 million USD | ? USD |
| 2009Q1 | -10.2 million USD | ? USD |
| 2008Q4 | -13.5 million USD | ? USD |
| 2008Q3 | -9.0 million USD | ? USD |
| 2008Q2 | -5.5 million USD | ? USD |
| 2008Q1 | -33.4 million USD | ? USD |
| 2007Q2 | -2.9 million USD | ? USD |
| 2007Q1 | -2.9 million USD | ? USD |
ALIM Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -20.1 million USD | 80.8 million USD |
| 2022 | -18.1 million USD | 54.1 million USD |
| 2021 | -4.4 million USD | 59.0 million USD |
| 2020 | -5.3 million USD | 50.8 million USD |
| 2019 | -10.4 million USD | 53.9 million USD |
| 2018 | -16.4 million USD | 47.0 million USD |
| 2017 | -22.0 million USD | 35.9 million USD |
| 2016 | -33.2 million USD | 34.3 million USD |
| 2015 | -30.6 million USD | 22.4 million USD |
| 2014 | -35.9 million USD | 8.4 million USD |
| 2013 | -46.2 million USD | 1.9 million USD |
| 2012 | -19.7 million USD | ? USD |
| 2011 | -22.5 million USD | ? USD |
| 2010 | -13.9 million USD | ? USD |
| 2009 | -44.2 million USD | ? USD |
| 2008 | -61.5 million USD | ? USD |
| 2007 | -5.7 million USD | ? USD |
| 2006 | -13.0 million USD | ? USD |
ALIM
Price: $3.65
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -2.36
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 7882
Ebitda: -3.1 millionMarket Capitalization: 191.2 million